Eckert & Ziegler SE (VIE:EUZG)

Austria flag Austria · Delayed Price · Currency is EUR
14.88
-0.16 (-1.06%)
At close: Feb 4, 2026
Market Cap941.74M -6.9%
Revenue (ttm)304.47M +9.6%
Net Income39.75M +35.3%
EPS0.63 +34.6%
Shares Outn/a
PE Ratio23.69
Forward PE17.64
Dividend0.17 (1.06%)
Ex-Dividend DateJun 19, 2025
Volumen/a
Average Volume316
Open15.02
Previous Close15.04
Day's Range14.88 - 15.04
52-Week Range14.30 - 23.02
Betan/a
RSI41.91
Earnings DateMar 26, 2026

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-co... [Read more]

Industry Industrial Inorganic Chemicals
Founded 1992
Employees 1,112
Stock Exchange Vienna Stock Exchange
Ticker Symbol EUZG
Full Company Profile

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.

Financial Statements